Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 2Depression 2Tuberous Sclerosis 1Tourette Syndrome 1Tic Disorders 1Preleukemia 1Neurodevelopmental Disorders 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Hot Flashes 1Hematologic Diseases 1Glioblastoma 1Fragile X Syndrome 1DiGeorge Syndrome 1Cytopenia 1Breast Neoplasms 1Bone Marrow Diseases 1Autistic Disorder 1Autism Spectrum Disorder 1Attention Deficit Disorder with Hyperactivity 1Anxiety Disorders 1Anemia 122q11 Deletion Syndrome 1

Interventions

Cytarabine 358Cyclophosphamide 241Azacitidine 213fludarabine phosphate 199venetoclax 198fludarabine 196Busulfan 148Decitabine 132Mycophenolic Acid 123Whole-Body Irradiation 122Peripheral Blood Stem Cell Transplantation 118Tacrolimus 115Granulocyte Colony-Stimulating Factor 104Idarubicin 100Filgrastim 100Melphalan 89Cyclosporine 89Methotrexate 83Daunorubicin 76Antilymphocyte Serum 75Etoposide 73Mitoxantrone 67Clofarabine 67Gemtuzumab 59Stem Cell Transplantation 55Thiotepa 51Cladribine 46Injections 45Specimen Handling 44thymoglobulin 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myeloid, Acute × Sertraline × Clear all
NCT02891278 2023-04-12

Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML

Columbia University

Phase 1 Completed
6 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡